Cargando…
Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis
Autores principales: | Meling, Maureen Tania, Minagawa, Akane, Miyake, Tomomi, Ashida, Atsuko, Okuyama, Ryuhei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577500/ https://www.ncbi.nlm.nih.gov/pubmed/34786446 http://dx.doi.org/10.1016/j.jdcr.2021.10.004 |
Ejemplares similares
-
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007) -
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
por: Nozaki, Yuji, et al.
Publicado: (2021) -
Near-ultraviolet Light Dermoscopy for Identification of Pigmented Skin Tumours
por: MINAGAWA, Akane, et al.
Publicado: (2023) -
Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
por: Furst, D E, et al.
Publicado: (2015) -
Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2020)